These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma. Bhattacharyya N Otolaryngol Head Neck Surg; 2003 Jan; 128(1):115-23. PubMed ID: 12574769 [TBL] [Abstract][Full Text] [Related]
25. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial. Asari R; Koperek O; Scheuba C; Riss P; Kaserer K; Hoffmann M; Niederle B Ann Surg; 2009 Jun; 249(6):1023-31. PubMed ID: 19474675 [TBL] [Abstract][Full Text] [Related]
27. [Surgical treatment of differentiated carcinoma of the thyroid. Follow-up of 99 cases]. Pozzetto B; Roseano M; Dellach C; Leggeri A Chir Ital; 2000; 52(1):49-56. PubMed ID: 10832526 [TBL] [Abstract][Full Text] [Related]
28. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival. Zidan J; Karen D; Stein M; Rosenblatt E; Basher W; Kuten A Cancer; 2003 Mar; 97(5):1181-5. PubMed ID: 12599223 [TBL] [Abstract][Full Text] [Related]
29. High recurrent rate of multicentric papillary thyroid carcinoma. Lin JD; Chao TC; Hsueh C; Kuo SF Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244 [TBL] [Abstract][Full Text] [Related]
31. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. Uchino S; Noguchi S; Kawamoto H; Yamashita H; Watanabe S; Yamashita H; Shuto S World J Surg; 2002 Aug; 26(8):897-902. PubMed ID: 11965446 [TBL] [Abstract][Full Text] [Related]
32. Prognostic factors in patients with differentiated thyroid carcinoma. Steinmüller T; Klupp J; Rayes N; Ulrich F; Jonas S; Gräf KJ; Neuhaus P Eur J Surg; 2000 Jan; 166(1):29-33. PubMed ID: 10688213 [TBL] [Abstract][Full Text] [Related]
35. Prognostic factors in follicular carcinoma of the thyroid--a multivariate survival analysis. Besic N; Auersperg M; Golouh R Eur J Surg Oncol; 1999 Dec; 25(6):599-605. PubMed ID: 10556007 [TBL] [Abstract][Full Text] [Related]
36. Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma. Orita Y; Sugitani I; Matsuura M; Ushijima M; Tsukahara K; Fujimoto Y; Kawabata K Surgery; 2010 Mar; 147(3):424-31. PubMed ID: 20176243 [TBL] [Abstract][Full Text] [Related]
37. Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma. Hay ID J Surg Oncol; 2006 Dec; 94(8):692-700. PubMed ID: 17131429 [TBL] [Abstract][Full Text] [Related]
38. Predictive value of AMES scoring system in selection of extent of surgery in well differentiated carcinoma of thyroid. Van Nguyen K; Dilawari RA Am Surg; 1995 Feb; 61(2):151-5. PubMed ID: 7856976 [TBL] [Abstract][Full Text] [Related]
39. [Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases]. Liu WS; Qi YF; Tang PZ Ai Zheng; 2004 Sep; 23(9):1081-4. PubMed ID: 15363207 [TBL] [Abstract][Full Text] [Related]
40. Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years. Brierley J; Tsang R; Panzarella T; Bana N Clin Endocrinol (Oxf); 2005 Oct; 63(4):418-27. PubMed ID: 16181234 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]